The Cigna Groupvs.McKesson
CI vs MCK · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
McKesson is about 1.4× larger than The Cigna Group by market cap; The Cigna Group trades at the lower P/E (11.8 vs 23.8); year to date, McKesson leads (+13.4% vs +2.1%).
Side by side
| CI | MCK | |
|---|---|---|
| Market cap | $75.4B | $109B |
| Price | $282.43 | $938.84 |
| Today | +0.5% | +0.9% |
| Return YTD | +2.1% | +13.4% |
| Return 1Y | −8.4% | +23.1% |
| Since June 26, 2026 | −0.1% | +23.0% |
| P/E | 11.8 | 23.8 |
| P/S | 0.3 | 0.3 |
| P/B | 1.8 | 18.6 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
The Cigna GroupCI
Express Scripts, the pharmacy benefit manager, sits at the centre. Around it Cigna writes health insurance and runs a specialty pharmacy and distribution business.
Full CI profile →McKessonMCK
Medicines reach the counter through wholesalers, and McKesson is one of them: its customers run from pharmacies to hospitals and clinics across the US. Alongside distribution it sells services to pharmacy operators and runs an oncology network.
Full MCK profile →More CI & MCK comparisons
Other head-to-heads in the Distribution & pharmacy infrastructure segment.